Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock

January 29, 2024

https://www.globenewswire.com/news-release/2024/01/29/2818645/0/en/Vera-Therapeutics-Announces-Proposed-Public-Offering-of-Class-A-Common-Stock.html

BRISBANE, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (“Vera”), a late clinical-stage biotechnology company developing and commercializing transformative treatments for patients with serious immunologic diseases, today announced its plans to commence a public offering, subject to market and other conditions, to issue and sell $200.0 million of shares of its Class A common stock. All of the shares are being offered by Vera.

Read more at globenewswire.com

Related news for (VERA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.